Is Takotsubo syndrome in patients receiving chemotherapy drug-specific?

作     者：John E Madias 

作者机构：Icahn School of Medicine at Mount Sinai Division of CardiologyElmhurst Hospital Center 

出 版 物：《World Journal of Clinical Cases》 (世界临床病例杂志)

年 卷 期：2015年第3卷第2期

页      面：204-205页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 100214[医学-肿瘤学] 10[医学] 

主　　题：Daunorubicin Radiotherapy Cardiotoxicity Takotsubo syndrome Malignancies Chemotherapy Cytarabine Anthracyclines Cardiomyopathy Autonomic sympathetic Nervous system 

摘      要：In commenting on a case report of a 55-year-old man who suffered Takotsubo syndrome(TTS), in the setting of receiving chemotherapy with cytarabine and daunorubicin for acute myeloid leukemia, the author expresses his views that TTS in the setting of chemotherapy for malignancies may not be chemotherapeutic drug-specific(like in the chemotherapeutic drug induced-cardiomyopathy), but may be due to the emotional and physical stresses resulting from the realization of having diagnosed with a malignancy, and the diagnostic testing, and therapeutic management which follows.